United States · FDA National Drug Code directory
Deferiprone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0054-0711_db72caee-70a3-4561-b855-08b4c9f4a0e0
- Product NDC
- 0054-0711
- Form
- TABLET, COATED
- Composition / generic term
- Deferiprone
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220208
- Source listing expiry
- 20261231
Source-listed ingredients
- DEFERIPRONE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 50 TABLET, COATED in 1 BOTTLE (0054-0711-19) · 0054-0711-19
- 150 TABLET, COATED in 1 BOTTLE (0054-0711-23) · 0054-0711-23
- 300 TABLET, COATED in 1 BOTTLE (0054-0711-28) · 0054-0711-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →